Cancer is a complex disease caused by genetic mutations and alterations. Traditional methods of studying cancer often involve labor-intensive and time-consuming procedures. CRISPR-based screening provides a rapid, efficient, and scalable approach for discovering genes involved in cancer development and progression. This can lead to the identification of novel therapeutic targets and a better understanding of cancer biology.
